Diagnostic Characteristics of Urea Cycle Disorders

Key Biochemical Features

The American College of Medical Genetics and Genomics recommends considering hyperammonemia as the defining feature of urea cycle disorders, with toxic levels >200 µmol/l associated with poor neurological outcomes 1, 2
Elevated glutamine accumulates as the end product of ammonia detoxification and is a key factor in ammonia-related neurotoxicity, according to the National Institutes of Health 2
Accumulation of specific substrates, such as citrulline, argininosuccinate, or ornithine, occurs depending on which enzyme is deficient in the urea cycle, as stated by the European Society for Pediatric Gastroenterology, Hepatology and Nutrition 1, 2
Respiratory alkalosis from hyperventilation can occur as ammonia levels rise, as reported by the American Thoracic Society 2

The American Academy of Pediatrics recommends using plasma ammonia levels as the primary screening test for urea cycle disorders 1, 2
Plasma amino acid analysis can help identify specific enzyme defects based on accumulation patterns, such as citrulline or argininosuccinate, according to the Society for Inherited Metabolic Disorders 1, 2
Organic acid analysis can help rule out organic acidemias that can cause secondary hyperammonemia, as suggested by the American College of Medical Genetics and Genomics 1, 2
The absence of significant ketosis during hypoglycemic episodes can help distinguish urea cycle disorders from other metabolic disorders, as noted by the Endocrine Society 3

The Genetics Society recommends considering glycogen storage disorders, such as GSD type 0, as a potential cause of alanine elevation, rather than urea cycle disorders 3
The pattern of metabolites must be interpreted as a whole, not based on individual abnormalities, to avoid confusing urea cycle disorders with other metabolic disorders, as cautioned by the American Medical Association 4